Back to Search
Start Over
Minimally Invasive Microincision Vitrectomy Surgery with an Intraoperative Dexamethasone Implant for Refractory Diabetic Macular Edema.
- Source :
-
Ophthalmologica . Apr2016, Vol. 235 Issue 3, p150-156. 7p. - Publication Year :
- 2016
-
Abstract
- Purpose: To evaluate the 1-year results of 25-gauge microincision vitrectomy surgery (MIVS25) combined with intraoperative dexamethasone (DEX) implant for persistent diabetic macular edema (DME). Methods: This study enrolled patients who had a history of DME for ⩾ 12 months and underwent MIVS25 and DEX implant injection. Best corrected visual acuity (BCVA) and central retinal thickness (CRT) were assessed postoperatively. Results: Eighteen eyes were included in the analysis. Preoperatively, logMAR BCVA was 0.90 and CRT was 594 μm on average. CRT decreased until the 3-month follow-up visit and tended to increase at 6 months, but stabilized at 12 months with additional treatments in five eyes at 5 months postoperatively. Statistically significant improvement in BCVA was noted 1 month after treatment and at each subsequent follow-up visit (p < 0.001). Conclusion: MIVS25 combined with DEX implant injection might be utilized as an effective and safe alternative treatment for intractable DME. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00303755
- Volume :
- 235
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Ophthalmologica
- Publication Type :
- Academic Journal
- Accession number :
- 115008771
- Full Text :
- https://doi.org/10.1159/000443751